In vitro activity of WY-49605, a penem antimicrobial

G M Eliopoulos1, C B Wennersten, G Cole

  • 1Department of Medicine, Deaconess Hospital One Deaconess Road, Boston, MA 02215, USA.

Insights

The novel penem antimicrobial WY-49605 shows strong in vitro activity against many Gram-positive bacteria, including methicillin-susceptible staphylococci and penicillin-susceptible streptococci. It is also effective against Enterobacteriaceae, Enterococcus faecalis, and Bacteroides fragilis.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • The emergence of antibiotic resistance necessitates the development of new antimicrobial agents.
  • Oral antimicrobial agents are crucial for treating a wide range of bacterial infections.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of the novel penem WY-49605.
  • To compare its activity with existing oral antimicrobial agents against various clinically relevant bacteria.

Main Methods:

  • Minimum inhibitory concentrations (MICs) were determined for WY-49605 and comparator agents against a panel of bacterial isolates.
  • MIC(90) values (concentrations inhibiting 90% of isolates) were calculated and compared.

Main Results:

  • WY-49605 demonstrated potent activity against methicillin-susceptible Staphylococcus (MIC(90) = 0.25 microg/ml) and penicillin-susceptible Streptococcus (MIC(90) <= 0.12 microg/ml).
  • It exhibited comparable or superior activity against other Gram-positive genera versus existing agents.
  • WY-49605 and cefpodoxime were the most active agents against Enterobacteriaceae.
  • Susceptibility was observed for Enterococcus faecalis and Bacteroides fragilis (MIC <= 4 microg/ml).
  • Pseudomonas aeruginosa, Enterococcus faecium, and methicillin-resistant Staphylococcus aureus showed resistance to all tested agents.

Conclusions:

  • WY-49605 is a promising oral penem antimicrobial with broad-spectrum activity against key Gram-positive pathogens and Enterobacteriaceae.
  • Its in vitro profile suggests potential utility in treating infections caused by susceptible bacteria, though resistance was noted in certain strains.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...